The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Alexandre Abizaid

Showing 1-20 of 43 articles
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Coronary interventions
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamié D, Abizaid An, Boersma E, Abizaid A
October 18, 2019 | 10.4244/EIJ-D-18-00292
Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial
Seth A, Onuma Y, Chandra P, Bahl V, Manjunath C, Mahajan A, Kumar V, Goel P, Wander G, Kaul U, Ajit Kumar V, Abizaid A, Serruys P
September 20, 2019 | 10.4244/EIJ-D-19-00324
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries
Caixeta A, Campos C, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, Costa Jr J, Onuma Y, van Geuns R, Bartorelli A, Colombo A, Tamburino C, Serruys P, Abizaid A
September 20, 2019 | 10.4244/EIJ-D-16-00796
Coronary interventions
Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study
Valdés Chávarri M, Kedev S, Neskovic A, de la Tassa CM, Zivkovic M, Nouche RT, Vázquez-González N, Bartorelli A, Antoniucci D, Tamburino C, Colombo A, Abizaid A, McFadden E, Garcia-Garcia H, Milasinovic D, Stankovic G
April 5, 2019 | 10.4244/EIJ-D-17-01087
Coronary interventions
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L, Dudek D, Weber-Albers J, Abizaid A, Christiansen E, Muller D, Kochman J, Kołtowski Ł, Lassen J, Wojdyla R, Wykrzykowska J, Onuma Y, Daemen J
December 7, 2018 | 10.4244/EIJ-D-18-00491
Coronary interventions
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial
Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S
December 7, 2018 | 10.4244/EIJ-D-18-00762
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease
Abdelghani M, Cavalcante R, Miyazaki Y, de Winter R, Tijssen J, Sarmento-Leite R, Mangione J, Abizaid A, Lemos P, Serruys P, de Brito Jr F
November 20, 2017 | 10.4244/EIJ-D-17-00328
Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores
Janella B, Campos C, Caixeta A, Almeida B, Sandoli de Brito Jr F, Abizaid A, Perin M
November 20, 2017 | 10.4244/EIJ-D-16-00659
Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”
Möllmann H, Walther T, Siqueira D, Diemert P, Treede H, Grube E, Nickenig G, Baldus S, Rudolph T, Kuratani T, Sawa Y, Kempfert J, Kim W, Abizaid A
October 11, 2017 | 10.4244/EIJ-D-17-00187
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
Interventions for valvular disease
The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique
Tateishi H, Abdelghani M, Cavalcante R, Miyazaki Y, Campos C, Collet C, Slots T, Leite R, Mangione J, Abizaid A, Soliman O, Spitzer E, Onuma Y, Serruys P, Lemos P, de Brito Jr F
May 15, 2017 | 10.4244/EIJ-D-16-00647
Coronary interventions
Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study
Collet C, Corral J, Cavalcante R, Tateishi H, Belzarez O, Costa J, Costa R, Chamié D, Onuma Y, de Winter R, Abizaid A, Serruys P
April 7, 2017 | 10.4244/EIJ-D-16-00868
Coronary interventions
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J, Verheye S, Abizaid A, Ormiston J, De Vries T, Morrison L, Toyloy S, Fitzgerald P, Windecker S, Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
Coronary interventions
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys P
November 20, 2016 | 10.4244/EIJV12I10A206
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Perin M, Seth A, Botelho R, Serruys P
June 19, 2015 | 10.4244/EIJY15M05_06
Coronary interventions
The ABS mother-daughter platforms
Khorsandi M, Abizaid A, Dani S, Bourang H, Costa R, Kar S, Makkar R
May 19, 2015 | 10.4244/EIJV11SVA36
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243

Latest news

EDITORIAL
A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…
June 11, 2021
NEW
Intracoronary OCT: State of the Art and Future Directions
Ziad A. Ali et al.
June 11, 2021
PCR Companion attending EuroPCR? Activate your free subscription!
May 28, 2021
TRIALS BOOK
Access the full Trials Book 2021
(Thanks to the support of Biotronik)
May 18, 2021
JAA
This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...
June 8, 2021
NEW
Joint EAPCI/ACVC expert consensus on pVADs
Alaide Chieffo et al.
May 31, 2021
JAA
New JAA's: Impact of HPR on clopidogrel monotherapy and more...
May 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke